The Human Collective Project (HCP) is TSF’s support group meetings offered to anyone who has been affected/impacted by NMOSD/MOGAD. The program came into existence during the height of the COVID-19 pandemic in 2020 when most NMOSD/MOGAD felt particularly isolated and vulnerable to the coronavirus as immunosuppressed/immunocompromised members of society. The isolation many of us experienced […]
Are you an NMOSD/MOGAD patient, caregiver, clinician, nurse, researcher and/or advocate in New England? You're invited! In collaboration with Dr. Michael Levy at Mass General Hospital, The Sumaira Foundation is pleased to invite you to TSF's New England Patient Day, a special day dedicated to NMOSD & MOGAD patients, caregivers, clinicians and researchers. Join us […]
The Human Collective Project (HCP) is TSF’s support group meetings offered to anyone who has been affected/impacted by NMOSD/MOGAD. The program came into existence during the height of the COVID-19 pandemic in 2020 when most NMOSD/MOGAD felt particularly isolated and vulnerable to the coronavirus as immunosuppressed/immunocompromised members of society. The isolation many of us experienced […]
Du inviteres til TSF's første danske webinar! Vi inviterer dansktalende patienter, plejere, klinikere, forskere og fortalere til at deltage i vores webinar - Forståelse af ligheder og forskelle mellem NMOSD, MOGAD og MS - med prof. Nasrin Asgari, neurolog ved Syddansk Universitet. Deltagere, der vil deltage i live-begivenheden, vil have mulighed for at stille spørgsmål […]
HCP is a great way to meet others in similar circumstances in this rare community; it is a safe space to laugh, cry, vent, share wins, etc. This program is driven and led by TSF Patient and Caregiver Ambassadors worldwide.
In deze webinar bespreken we de snel veranderende kennis over immuuntherapie bij NMOSD en MOGAD. Welke behandelingen gebruiken we nu? Welke nieuwe behandelingen zijn recent goedgekeurd? En wat heeft de toekomst in petto aan mogelijke innovatieve behandelingsopties? Prof. Dr. Barbara Willekens, Universitair Ziekenhuis Antwerpen en Universiteit Antwerpen, België en dr. Beatrijs Wokke, Erasmus Medisch Centrum […]
Sie sind zum kommenden Webinar von TSF Deutschland eingeladen: Was Betroffene über NMOSD und MOGAD wissen sollten. Besuchen Sie uns am Dienstag, den 19. März um 19:00 Uhr MEZ zu einer aufschlussreichen Diskussion mit Dr. Joachim Havla (Ludwig-Maximilians-Universität München) über alles, was Sie über NMOSD und MOGAD wissen müssen! Teilnehmer des Live-Webinars haben die Möglichkeit, […]
El Human Collective Project (HCP) es la reunión del grupo de apoyo de TSF que se ofrece a cualquier persona que haya sido afectada/impactada por NMOSD/MOG-AD. El programa nació durante el apogeo de la pandemia de COVID-19 en 2020, cuando la mayoría de los NMOSD/MOG-AD se sentían particularmente aislados y vulnerables al coronavirus como miembros […]
Per celebrare il Mese della Consapevolezza NMO 2024, TSF Italia ti invita a partecipare a un webinar molto speciale con il Professor Luca Massacesi e la Dott.ssa Sara Mariotto mercoledì 20 marzo alle 18:00 CET. In questo webinar in formato intervista, verrà fatto un excursus storico sulla neuromielite ottica, toccando anche diversi aspetti tra cui […]
Para celebrar o Mês de Conscientização sobre NMO 2024, convidamos pacientes, cuidadores, médicos e pesquisadores de língua portuguesa a participarem do primeiro webinar português da TSF: Compreendendo as semelhanças e diferenças entre DENMO, MOGAD e EM. Este webinar ao vivo contará com a participação do Professor Jefferson Becker, da Pontifícia Universidade Católica do Rio Grande […]
A l'occasion du mois de sensibilisation à la NMOSD, le docteur Cécile Donzé nous fait le plaisir de venir aborder avec TSF France la rééducation et la réadaptation dans les maladies neurologiques (NMOSD, Mogad et Sclérose en plaques (SEP)). Toutes ces maladies se caractérisent par l'apparition de handicaps plus ou moins visibles mais qui ne […]
The Human Collective Project (HCP) est la réunion du groupe de soutien de TSF offerte à toute personne affectée par la NMOSD ou la MOGAD. Le programme a vu le jour au plus fort de la pandémie de COVID-19 en 2020, lorsque la plupart des patients NMOSD/MOGAD se sentaient particulièrement isolés et vulnérables au coronavirus […]
